midazolam
Midazolam Injection, USP CIV(For Intravenous or Intramuscular Use Only)
Approved
Approval ID
c33919da-1d84-ed01-a5e5-62330407336e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 1, 2022
Manufacturers
FDA
Almaject, Inc.
DUNS: 116626205
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
midazolam
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72611-741
Application NumberANDA090696
Product Classification
M
Marketing Category
C73584
G
Generic Name
midazolam
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateDecember 13, 2016
FDA Product Classification
INGREDIENTS (5)
edetate disodiumInactive
Code: 7FLD91C86K
Classification: IACT
midazolam hydrochlorideActive
Quantity: 1 mg in 1 mL
Code: W7TTW573JJ
Classification: ACTIM
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT